Screener
BioCryst Pharmaceuticals BCRX Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: BioCryst Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053300
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Deferred revenue | 13,461 | — |
| Total liabilities | 1,012,140 | 633,311 |
| Stockholders’ deficit: | ||
| Preferred stock, $0.01 par value; shares authorized - 5,000; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.01 par value; shares authorized - 450,000; shares issued and outstanding – 255,265 at June 30, 2026 and 213,060 at December 31, 2025 | 2,553 | 2,131 |
| Additional paid-in capital | 1,693,282 | 1,384,857 |
| Accumulated other comprehensive (loss) income | (528) | 38 |
| Accumulated deficit | (2,149,596) | (1,506,179) |
Item 1. Financial Statements (Unaudited):
FAQ
- What is BioCryst Pharmaceuticals's preferred stock, shares authorized?
- BioCryst Pharmaceuticals (BCRX) reported preferred stock, shares authorized of $5M in Q2 2026.
- How has BioCryst Pharmaceuticals's preferred stock, shares authorized changed year-over-year?
- BioCryst Pharmaceuticals's preferred stock, shares authorized decreased by 0.0% year-over-year, from $5M to $5M.
- What is the long-term trend for BioCryst Pharmaceuticals's preferred stock, shares authorized?
- Over 3 years (2022 to 2025), BioCryst Pharmaceuticals's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from $5M to $5M.
- What does preferred stock, shares authorized mean?
- Preferred Stock, Shares Authorized
Ask your AI about BioCryst Pharmaceuticals's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude